• Medientyp: E-Artikel
  • Titel: Clinical and cardiac magnetic resonance findings in post-COVID patients referred for suspected myocarditis
  • Beteiligte: Breitbart, Philipp; Koch, Alexander; Schmidt, Marco; Magedanz, Annett; Lindhoff-Last, Edelgard; Voigtländer, Thomas; Schmermund, Axel; Mehta, Rajendra H.; Eggebrecht, Holger
  • Erschienen: Springer Science and Business Media LLC, 2021
  • Erschienen in: Clinical Research in Cardiology
  • Sprache: Englisch
  • DOI: 10.1007/s00392-021-01929-5
  • ISSN: 1861-0692; 1861-0684
  • Schlagwörter: Cardiology and Cardiovascular Medicine ; General Medicine
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:sec> <jats:title>Objectives</jats:title> <jats:p>We assessed possible myocardial involvement in previously cardiac healthy post-COVID patients referred for persisting symptoms with suspected myocarditis.</jats:p> </jats:sec><jats:sec> <jats:title>Background</jats:title> <jats:p>Prior studies suggested myocardial inflammation in patients with coronavirus-induced disease 2019 (COVID-19). However, the prevalence of cardiac involvement among COVID patients varied between 1.4 and 78%.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>A total of 56 post-COVID patients without previous heart diseases were included consecutively into this study. All patients had positive antibody titers against SARS-CoV-2. Patients were referred for persistent symptoms such as chest pain/discomfort, shortness of breath, or intolerance to activity. All patients underwent standardized cardiac assessment including electrocardiogram (ECG), cardiac biomarkers, echocardiography, and cardiac magnetic resonance (CMR).</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>56 Patients (46 ± 12 years, 54% females) presented 71 ± 66 days after their COVID-19 disease. In most patients, the course of COVID-19 was mild, with hospital treatment being necessary in five (9%). At presentation, patients most often reported persistent fatigue (75%), chest pain (71%), and shortness of breath (66%). Acute myocarditis was confirmed by T1/T2-weighed CMR and elevated NTpro-BNP levels in a single patient (2%). Left ventricular ejection fraction was 56% in this patient. Additional eight patients (14%) showed suspicious CMR findings, including myocardial edema without fibrosis (<jats:italic>n</jats:italic> = 3), or non-ischemic myocardial injury suggesting previous inflammation (<jats:italic>n</jats:italic> = 5). However, myocarditis could ultimately not be confirmed according to 2018 Lake Louise criteria; ECG, echo and lab findings were inconspicuous in all eight patients.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Among 56 post-COVID patients with persistent thoracic complaints final diagnosis of myocarditis could be confirmed in a single patient using CMR.</jats:p> </jats:sec><jats:sec> <jats:title>Graphic abstract</jats:title> </jats:sec>